185 related articles for article (PubMed ID: 32931878)
1. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2021 Feb; 74(2):303-311. PubMed ID: 32931878
[TBL] [Abstract][Full Text] [Related]
2. An educate, test and treat model towards elimination of hepatitis C infection in Egypt: Feasibility and effectiveness in 73 villages.
Shiha G; Soliman R; Mikhail NNH; Easterbrook P
J Hepatol; 2020 Apr; 72(4):658-669. PubMed ID: 31734097
[TBL] [Abstract][Full Text] [Related]
3. An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
Shiha G; Metwally AM; Soliman R; Elbasiony M; Mikhail NNH; Easterbrook P
Lancet Gastroenterol Hepatol; 2018 Nov; 3(11):778-789. PubMed ID: 30030068
[TBL] [Abstract][Full Text] [Related]
4. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
[TBL] [Abstract][Full Text] [Related]
5. Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention.
Ayoub HH; Abu-Raddad LJ
J Viral Hepat; 2017 Jun; 24(6):486-495. PubMed ID: 28039923
[TBL] [Abstract][Full Text] [Related]
6. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data.
Boettiger DC; Law MG; Dore GJ; Guy R; Callander D; Donovan B; O'Connor CC; Fairley CK; Hellard M; Matthews G
BMC Infect Dis; 2017 Dec; 17(1):740. PubMed ID: 29191154
[TBL] [Abstract][Full Text] [Related]
8. Systematic overview of hepatitis C infection in the Middle East and North Africa.
Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
[TBL] [Abstract][Full Text] [Related]
9. Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study.
Breban R; Arafa N; Leroy S; Mostafa A; Bakr I; Tondeur L; Abdel-Hamid M; Doss W; Esmat G; Mohamed MK; Fontanet A
Lancet Glob Health; 2014 Sep; 2(9):e541-e549. PubMed ID: 25304421
[TBL] [Abstract][Full Text] [Related]
10. Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination.
Kåberg M; Navér G; Hammarberg A; Weiland O
J Viral Hepat; 2018 Dec; 25(12):1452-1461. PubMed ID: 29998522
[TBL] [Abstract][Full Text] [Related]
11. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations.
Omran D; Alboraie M; Zayed RA; Wifi MN; Naguib M; Eltabbakh M; Abdellah M; Sherief AF; Maklad S; Eldemellawy HH; Saad OK; Khamiss DM; El Kassas M
World J Gastroenterol; 2018 Oct; 24(38):4330-4340. PubMed ID: 30344418
[TBL] [Abstract][Full Text] [Related]
12. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
[TBL] [Abstract][Full Text] [Related]
13. Intrafamilial transmission of hepatitis C in Egypt.
Mohamed MK; Abdel-Hamid M; Mikhail NN; Abdel-Aziz F; Medhat A; Magder LS; Fix AD; Strickland GT
Hepatology; 2005 Sep; 42(3):683-7. PubMed ID: 16032698
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for hepatitis C infection in a cohort of women in rural Egypt.
Saleh DA; Shebl F; Abdel-Hamid M; Narooz S; Mikhail N; El-Batanony M; El-Kafrawy S; El-Daly M; Sharaf S; Hashem M; El-Kamary S; Magder LS; Stoszek SK; Strickland GT
Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):921-8. PubMed ID: 18514243
[TBL] [Abstract][Full Text] [Related]
15. Micro-elimination of hepatitis C through testing of Egyptian pregnant women presenting at delivery: implications for screening policies.
Mostafa A; Ebeid FSE; Khaled B; Ahmed RHM; El-Sayed MH
Trop Med Int Health; 2020 Jul; 25(7):850-860. PubMed ID: 32306545
[TBL] [Abstract][Full Text] [Related]
16. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
17. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study.
Olafsson S; Fridriksdottir RH; Love TJ; Tyrfingsson T; Runarsdottir V; Hansdottir I; Bergmann OM; Björnsson ES; Johannsson B; Sigurdardottir B; Löve A; Baldvinsdottir GE; Hernandez UB; Gudnason T; Heimisdottir M; Hellard M; Gottfredsson M
Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):628-637. PubMed ID: 34171267
[TBL] [Abstract][Full Text] [Related]
18. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
[TBL] [Abstract][Full Text] [Related]
19. Mass screening for hepatitis B and C in Southern Upper Egypt.
Soliman G; Elzalabany MS; Hassanein T; Miller FD
BMC Public Health; 2019 Oct; 19(1):1326. PubMed ID: 31640639
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
